Soon to be a Pharmaceutical Behemoth.
I would like to introduce everyone toIncannexHealthcare Limited - IHL
Progress.
2019 AGM Presentation - https://youtu.be/cChYzDncNz4 - From Chief medical officer Dr Sud Agarwal.
Aug 2020 - Small Caps interview - https://www.youtube.com/watch?v=2cCm1pdWHzM - Using medicinal cannabis to treat illnesses with unmet needs.
2021 - TradingForMillions Summary - https://tradingformillions.com/were-back-folks-why-incannex-healthcare-is-growing-into-the-next-billion-dollar-behemoth/
6 Month Price Sensitive Announcements - Screen Shot - Attached.
Additional notes:
- Currently in a Trading Halt - 5th Clinical Trial Pathway to be announced.
- Listing on US exchange.
- Outstanding CEO in Joel Latham backed by world leading medical & management team - All with skin in the game.
- $$ in bank - No raise.
- IP protection & on-going filings.
- Seeking FDA approval for emergency use of IHL-675A to treat Covid patients.
- Recruitment has commenced for Sleep Apnea Clinical Trial @ Alfred Hospital.
- Partnership with Monash University to conduct a world-first clinical trial: Psilocybin-assisted psychotherapy in the treatment of Generalised Anxiety Disorder.
- Appointment of EAS Advisors to facilitate introductions to US banks and institutions with the intention to list on a US main market.
- Positive in vivo results confirm strong synergistic neuroprotective activity of IHL-216A after traumatic brain injury.
- Expansion of use of IHL-675A to include COPD, asthma, bronchitis, and other inflammatory lung conditions - after receiving positive results from additional in vivo studies.
So much more - Good luck to all - Hopefully the above offers a chance for everyone to do some research into this Australian company that will be known worldwide in a very short time.
